CMS finalizes rule to promote value-based drug purchasing agreements

Negotiations of drug prices are to be based on clinical outcomes; if the drug is not effective, the payer is not held accountable for the full price.
Negotiations of drug prices are to be based on clinical outcomes; if the drug is not effective, the payer is not held accountable for the full price.

Read the full post on News Feed

MalloryHackett